UIM1:F:F-UBS ETF SICAV - Euro Stoxx 50 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 55.61

Change

-0.22 (-0.39)%

Market Cap

USD 0.58B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.38 (+0.74%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

+5.34 (+0.97%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.32 (+0.56%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.10 (+0.68%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.55 (+0.68%)

USD 52.44B
VUSA:F Vanguard Funds Public Limited ..

+0.22 (+0.22%)

USD 51.63B
0ZC:F Zscaler Inc

-0.95 (-0.43%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.46 (+0.36%)

USD 24.77B

ETFs Containing UIM1:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.94% 85% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.94% 85% B 75% C
Trailing 12 Months  
Capital Gain 8.15% 73% C 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.15% 71% C- 59% D-
Trailing 5 Years  
Capital Gain 89.31% 81% B- 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 89.31% 81% B- 56% F
Average Annual (5 Year Horizon)  
Capital Gain 10.46% 73% C 67% D+
Dividend Return 10.46% 70% C- 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.38% 47% F 84% B
Risk Adjusted Return 78.19% 78% C+ 83% B
Market Capitalization 0.58B 63% D 50% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.